39.0
IN8bio, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
22.2
FY23:
24.6
FY24:
12.6
FY25:
27.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.24
FY22:
10.8
FY23:
9.08
FY24:
8.37
FY25:
4.40
Total assets
Change from FY21 to FY25
millions USD
FY21:
42.2
FY22:
33.0
FY23:
33.7
FY24:
20.9
FY25:
32.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.26
FY22:
5.82
FY23:
5.39
FY24:
3.08
FY25:
3.16
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.78
FY22:
4.49
FY23:
3.38
FY24:
3.38
FY25:
1.56
(positive)
Change from FY21 to FY25
millions USD
FY21:
38.2
FY22:
22.7
FY23:
24.9
FY24:
14.5
FY25:
27.6
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
42.2
FY22:
33.0
FY23:
33.7
FY24:
20.9
FY25:
32.3
All amounts in millions USD